Moreover, Cu supplement could polarize macrophages to pro-inflammatory M1 phenotype by activating Cu-transport signaling such as ATP7A in macrophages [46], suggesting that ATP7A-mediated Cu efflux may also involve in the macrophage polarization, contributing to the inflammation of IBD. Here, ATP7A is linked to inflammatory bowel disease.